ciclosporin analogs (Enanta)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameciclosporin analogs (Enanta)
Drug Alias Nameimmunosuppressant program (Enanta)EP-314EP-1269EP-861EP-012637
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCalcineurin inhibitorsImmunosuppressants
TargetsCalcineurin
Therapy Area/IndicationsRejection of organ transplantationPsoriasisPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnanta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationPsoriasisPulmonary Disease, Chronic Obstructive +[5] 

Other Information

ATC CodeN/A
Related LinksN/A